|
(P198) |
Rolle von Biomarkern zur Bestimmung des metabolischen Status und Prädiktion der Herzfunktion vor und nach TAVI |
| |
|
A. Haase-Fielitz, M. Härdrich, O. Pivovarova, V. Sliziuk, F. Fulde, A. Hübner, N. Rudovich, A. Pfeiffer, C. Butter, für die Studiengruppe: NUTREXIA (Bernau bei Berlin, Potsdam; Bülach, CH) |
|
(P199) |
Long-term left-ventricular cardiac remodeling after aortic valve replacement evaluated by advanced quantitative CMR |
| |
|
N. Rank, L. Stoiber, A. Meyer, V. Falk, B. Pieske, S. Kelle (Berlin) |
|
(P200) |
Event lengths of sleep disordered breathing relate to signs of heart failure in patients with severe mitral regurgitation and may be reversed by MitraClip implantation |
| |
|
S. Klose, M. Spieker, J. Spießhöfer, S. Keymel, M. Boentert, S. Krüger, P. Horn, M. Kelm, R. Westenfeld (Düsseldorf, Münster) |
|
(P201) |
Procedural and anatomical predictors of renal denervation efficacy using two radiofrequency renal denervation catheters in a porcine model |
| |
|
M. A. Wolf, B. Hubbard, A. Sakaoka, S. Rousselle, A. Tellez, X. Jiang, K. Kario, M. Hohl, M. Böhm, F. Mahfoud (Homburg/Saar; Durnham, Thurmont, US; Kanagawa, Tochigi, JP; Beijing, CN) |
|
(P202) |
Early Transendocardial Autologous Bone Marrow Injection of Bone Marrow Derived Mononuclear Cells following Ischemic Myocardial Events.
The Helix Phase I Trial |
| |
|
C. Paitazoglou, C.-H. Heeger, K. Jaquet, K.-H. Kuck, C. Boosfeld, P. A. Altman, H. Thiele, M. W. Bergmann (Hamburg, Lübeck, Leipzig; San Carlos, US) |
|
(P203) |
Clinical profiles, outcome and prognostic factors of patients treated with percutaneous left ventricular assist devices |
| |
|
M. Noutsias, M. Ali, M. Mammadov, M. Matiakis, H. Melnyk, F. Höpfner, S. Witte, A. Rigopoulos (Halle (Saale)) |